Cerity Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
5,380
-1,492
| -22% | -$360K | ﹤0.01% | 1410 |
|
|
2025
Q1 | $1.67M | Sell |
6,872
-607
| -8% | -$148K | ﹤0.01% | 1198 |
|
|
2024
Q4 | $2.5M | Sell |
7,479
-314
| -4% | -$105K | 0.01% | 1007 |
|
|
2024
Q3 | $2.61M | Buy |
7,793
+1,767
| +29% | +$591K | 0.01% | 969 |
|
|
2024
Q2 | $1.65M | Sell |
6,026
-1,723
| -22% | -$471K | ﹤0.01% | 996 |
|
|
2024
Q1 | $2.68M | Buy |
7,749
+6,858
| +770% | +$2.37M | 0.01% | 862 |
|
|
2023
Q4 | $288K | Buy |
+891
| New | +$288K | ﹤0.01% | 1538 |
|
|
2023
Q2 | – | Sell |
-953
| Closed | -$877K | – | 1673 |
|
|
2023
Q1 | $877K | Buy |
953
+115
| +14% | +$106K | ﹤0.01% | 1036 |
|
|
2022
Q4 | $352K | Buy |
838
+336
| +67% | +$141K | ﹤0.01% | 1089 |
|
|
2022
Q3 | $209K | Buy |
502
+65
| +15% | +$27.1K | ﹤0.01% | 1041 |
|
|
2022
Q2 | $216K | Buy |
+437
| New | +$216K | ﹤0.01% | 1049 |
|
|
2022
Q1 | – | Sell |
-371
| Closed | -$282K | – | 951 |
|
|
2021
Q4 | $282K | Buy |
+371
| New | +$282K | ﹤0.01% | 798 |
|
|
2019
Q2 | – | Sell |
-707
| Closed | -$216K | – | 494 |
|
|
2019
Q1 | $216K | Buy |
+707
| New | +$216K | 0.01% | 485 |
|